Your browser doesn't support javascript.
loading
Antiapoptotic serine protease inhibitors contribute to survival of allergenic TH2 cells.
Shamji, Mohamed H; Temblay, Jeff N; Cheng, Wei; Byrne, Susan M; Macfarlane, Ellen; Switzer, Amy R; Francisco, Natalia D C; Olexandra, Fedina; Jacubczik, Fabian; Durham, Stephen R; Ashton-Rickardt, Philip G.
Afiliação
  • Shamji MH; Immunomodulation and Tolerance Group, London, United Kingdom; Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Temblay JN; Section of Immunobiology, Division of Inflammation and Immunology, Department of Medicine, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Cheng W; Section of Immunobiology, Division of Inflammation and Immunology, Department of Medicine, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Byrne SM; Section of Immunobiology, Division of Inflammation and Immunology, Department of Medicine, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Macfarlane E; Immunomodulation and Tolerance Group, London, United Kingdom; Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Switzer AR; Immunomodulation and Tolerance Group, London, United Kingdom; Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Francisco NDC; Immunomodulation and Tolerance Group, London, United Kingdom; Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Olexandra F; Immunomodulation and Tolerance Group, London, United Kingdom.
  • Jacubczik F; Section of Immunobiology, Division of Inflammation and Immunology, Department of Medicine, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Durham SR; Immunomodulation and Tolerance Group, London, United Kingdom; Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Ashton-Rickardt PG; Section of Immunobiology, Division of Inflammation and Immunology, Department of Medicine, Faculty of Medicine, Imperial College London, London, United Kingdom. Electronic address: p.ashton-rickardt@imperial.ac.uk.
J Allergy Clin Immunol ; 142(2): 569-581.e5, 2018 08.
Article em En | MEDLINE | ID: mdl-29106998
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Serpinas / Células Th2 / Mediadores da Inflamação / Hipersensibilidade / Antígenos de Neoplasias Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Serpinas / Células Th2 / Mediadores da Inflamação / Hipersensibilidade / Antígenos de Neoplasias Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article